GlassScriptPhysician profile
Fallon Marlene Labarge
NPI 1023657780
$1,376.69
in general payments reported to CMS, 2019-2025
12 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $727 · 2024: $330 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,300 · Travel and Lodging: $76.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.03 |
| Travel and Lodging | $76.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $250.36 | 2023-2025 | |
| Kerecis Limited | $233.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $150.00 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $146.09 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Aroa Biosurgery Incorporated | $125.50 | 2024 | |
| Kci USA, INC. | $98.74 | 2023 | Prevena |
| Stryker Corporation | $94.88 | 2023 | Na |
| Avita Medical Americas, LLC | $92.51 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Motiva USA, LLC | $70.78 | 2025 | |
| Ethicon US, LLC | $66.85 | 2024 | Stratafix |
| Organogenesis INC. | $31.01 | 2025 | Puraply Wound Matrix |
| Smith+Nephew, INC. | $16.15 | 2025 | Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fallon Labarge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.